Abstract:Recent advances in mouse models of experimental asthma coupled with vast improvements in systems that assess respiratory physiology have considerably increased the accuracy and human relevance of the outputs from these studies. In fact, these models have become important pre-clinical testing platforms with proven value and their capacity to be rapidly adapted to interrogate emerging clinical concepts, including the recent discovery of different asthma phenotypes and endotypes, has accelerated the discovery of disease-causing mechanisms and increased our understanding of asthma pathogenesis and the associated effects on lung physiology. In this review, we discuss key distinctions in respiratory physiology between asthma and severe asthma, including the magnitude of airway hyperresponsiveness and recently discovered disease drivers that underpin this phenomenon such as structural changes, airway remodeling, airway smooth muscle hypertrophy, altered airway smooth muscle calcium signaling, and inflammation. We also explore state-of-the-art mouse lung function measurement techniques that accurately recapitulate the human scenario as well as recent advances in precision cut lung slices and cell culture systems. Furthermore, we consider how these techniques have been applied to recently developed mouse models of asthma, severe asthma, and asthma-chronic obstructive pulmonary disease overlap, to examine the effects of clinically relevant exposures (including ovalbumin, house dust mite antigen in the absence or presence of cigarette smoke, cockroach allergen, pollen, and respiratory microbes) and to increase our understanding of lung physiology in these diseases and identify new therapeutic targets. Lastly, we focus on recent studies that examine the effects of diet on asthma outcomes, including high fat diet and asthma, low iron diet during pregnancy and predisposition to asthma development in offspring, and environmental exposures on asthma outcomes. We conclude our review with a discussion of new clinical concepts in asthma and severe asthma that warrant investigation and how we could utilize mouse models and advanced lung physiology measurement systems to identify factors and mechanisms with potential for therapeutic targeting.

Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance

Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance

Recent advances in pre-clinical mouse models of COPD

Advances in respiratory physiology in mouse models of experimental asthma

Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models

Recent Advances on Animal Models Related to Chronic Obstructive Pulmonary Disease

COPD: preclinical models and emerging therapeutic targets

Experimental animal models for COPD: a methodological review

Advances in animal models of chronic obstructive pulmonary disease

Experimental Mouse Models and Human Lung Organoid Models for Studying Chronic Obstructive Pulmonary Disease

Use of alternative animals as asthma models

Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD)

Neutrophilic Inflammation in the Immune Responses of Chronic Obstructive Pulmonary Disease: Lessons from Animal Models

A novel approach to investigate severe asthma and COPD: the 3d ex vivo respiratory mucosa model

2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis

Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?

Research Progress of COPD Mouse Models

Small-Airway Dysfunction is Involved in the Pathogenesis of Asthma: Evidence from Two Mouse Models.

Cytokine-targeted therapies for asthma and COPD

A review of chronic obstructive pulmonary disease model

Research progress of animal models of chronic obstructive pulmonary disease